New Positions
0 managers initiated
Top five by reported value
No new institutional positions this quarter.
Lyell Immunopharma Inc NASDAQ NMS - GLOBAL MARKET:LYEL
Institutional holders, quarter-over-quarter share deltas, and new and closed positions disclosed in Form 13F. Period 2025-12-31 · prior 2025-09-30.
0 new1 added0 reduced4 exited
Total Institutional Holders
1
as of 2025-12-31
Top Holder
Decheng Capital LLC
$21.3M
Largest QoQ Increase
Decheng Capital LLC
+96,584 sh
Largest QoQ Decrease
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
-1,604,676 sh
Added To(1)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| Decheng Capital LLC | 692,050 | +96,584 | $21.3M | +$11.6M | 16.2% |
Sold Out(4)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| NEW YORK STATE COMMON RETIREMENT FUND | 0 | -617,159 | $0 | -$1.3M | — |
| TAKEDA PHARMACEUTICAL CO LTD | 0 | -54,887 | $0 | -$891.4K | — |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0 | -1,604,676 | $0 | -$863.3K | — |
| Royal Bank of Canada | 0 | -19,746 | $0 | -$11.0K | — |
Top Holders by reported value
Ranked by the dollar value reported on the latest Form 13F. Share counts reflect long positions as of 2025-12-31.
| Manager | Shares | $ Value | Δ Shares | QoQ % |
|---|---|---|---|---|
| Decheng Capital LLC | 692,050 | $21.3M | +96,584 | 16.2% |
New & Closed Positions this quarter
Closed Positions
4 managers exited
Top five by prior-quarter value
Methodology
Form 13F is the SEC's quarterly disclosure for institutional investment managers exercising discretion over $100 million or more in qualifying U.S. equity securities. Managers must file within 45 days of each calendar quarter end, which is why holdings shown here reflect a snapshot at the period date — not real-time positioning.
Quarter-over-quarter deltas compare each manager's most recently reported share count for LYEL against its prior-quarter count. New positions are entries where the prior count was zero; closed positions are entries where the current count is zero. Amendments (13F-HR/A) replace prior filings for the same period.
Source: SEC EDGAR Form 13F (XML information tables). Dollar values are as reported by the manager and may use mid-quarter pricing conventions. CUSIP-to-ticker resolution is best-effort.